понедельник, 24 октября 2016 г.

An apology to Medarex CEO Howard Pien, 7 years in the making

An apology to Medarex CEO Howard Pien, 7 years in the making


Seven years ago, when I was a reporter covering the pharmaceutical industry for CBSNews.com, I became interested in a small company called Medarex. The company caught my eye because it was developing a drug for prostate cancer called ipilimumab.



from Biotech News